Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nestle Health Science Plans Continuum Of Care

This article was originally published in The Tan Sheet

Executive Summary

Nestle's announcement that its Health Science division is buying gastrointestinal drug developer and diagnostics firm Prometheus Laboratories takes the food company in a new direction, raising questions about Nestle's possible pharmaceutical play.
Advertisement

Related Content

Nestle China JV Backs Nutritional And Rx Botanical Development
Nestle China JV Backs Nutritional And Rx Botanical Development
In Brief
In Brief
In Brief
Nestle Dovetails Health Sciences Offerings With Purchase Of Diagnostics Firm
Nestle Dovetails Health Sciences Offerings With Purchase Of Diagnostics Firm
Nestle Claims "Pioneer" Mantle With Nutrition Business Expansion

Topics

Advertisement
UsernamePublicRestriction

Register

PS105155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel